Gudrun Hefner
Impact in
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
Papers in
-
- Schizophrenia research and treatment 12
- Electroconvulsive Therapy Studies 4
-
- Pharmaceutical Practices and Patient Outcomes 10
- Co-authors
- Christoph Hiemke (26 shared papers)A. Klimke (10 shared papers)Tanja Falter (7 shared papers)Stefan Unterecker (5 shared papers)Sermin Toto (8 shared papers)Jan Wolff (8 shared papers)Mohamed E. E. Shams (3 shared papers)Martina Hahn (7 shared papers)
- Journals
- Journal of Neural Transmission (7 papers)Pharmacopsychiatry (4 papers)Frontiers in Psychiatry (2 papers)European Journal of Clinical Pharmacology (2 papers)PLoS ONE (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Gudrun Hefner
34 papers receiving 585 citations
Peers
Comparison fields: 5 of 81
- Geriatrics and Gerontology 83
- Biological Psychiatry 31
- Psychiatry and Mental health 153
- Toxicology 24
- Pharmacology 55
Countries citing papers authored by Gudrun Hefner
This map shows the geographic impact of Gudrun Hefner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gudrun Hefner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gudrun Hefner more than expected).
Fields of papers citing papers by Gudrun Hefner
This network shows the impact of papers produced by Gudrun Hefner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gudrun Hefner. The network helps show where Gudrun Hefner may publish in the future.
Co-authors
The 25 scholars most cited alongside Gudrun Hefner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 64 | |
| 2 | 2017 | 43 | |
| 3 | 2014 | 43 | |
| 4 | 2020 | 36 | |
| 5 | 2021 | 33 | |
| 6 | 2021 | 29 | |
| 7 | 2014 | 27 | |
| 8 | 2014 | 25 | |
| 9 | 2020 | 23 | |
| 10 | 2018 | 21 | |
| 11 | 2021 | 21 | |
| 12 | 2020 | 20 | |
| 13 | 2014 | 20 | |
| 14 | 2013 | 20 | |
| 15 | 2020 | 18 | |
| 16 | 2018 | 18 | |
| 17 | 2015 | 18 | |
| 18 | 2021 | 17 | |
| 19 | 2022 | 15 | |
| 20 | Rating The Delirogenic Potential of Drugs for Prediction of Side Effects in Elderly Psychiatric Inpatients | 2015 | 11 |
About Gudrun Hefner
Gudrun Hefner is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology, Pharmacology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health, having authored 35 papers that have together received 593 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (12 papers), Pharmaceutical Practices and Patient Outcomes (10 papers), Treatment of Major Depression (7 papers), Electroconvulsive Therapy Studies (4 papers), Cardiac electrophysiology and arrhythmias (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Tryptophan and brain disorders (3 papers). The work is most often cited by research in Geriatrics and Gerontology (83 citations), Biological Psychiatry (31 citations), Psychiatry and Mental health (153 citations), Toxicology (24 citations) and Pharmacology (55 citations). Gudrun Hefner has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Christoph Hiemke, A. Klimke, Tanja Falter, Stefan Unterecker, Sermin Toto, Jan Wolff, Mohamed E. E. Shams, Martina Hahn, Ursula Voss and Ekkehard Haen. Their work appears in journals such as Journal of Neural Transmission, Pharmacopsychiatry, Frontiers in Psychiatry, European Journal of Clinical Pharmacology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.